Hi Welcome You can highlight texts in any article and it becomes audio news that you can hear
  • Tue. Nov 5th, 2024

Serum Institute prepares 40m dosages of Covid vaccine under ‘at risk’ manufacturing, stockpiling licence

Byindianadmin

Nov 13, 2020 #Institute, #Serum

In order to guarantee early availability of its Covid-19 vaccine when authorized, Pune-based Serum Institute of India (SII) has currently made 40 million dosages of the prospect developed by Oxford University and AstraZeneca, under the ‘at-risk’ manufacturing …
Read More

Click to listen highlighted text!